Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Renal Cell × Denosumab × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Neoplasms 8 Prostatic Neoplasms 6 Multiple Myeloma 5 Fractures, Bone 4 Neoplasm Metastasis 3 Bone Diseases, Metabolic 3 Spinal Cord Compression 2 Parathyroid Neoplasms 2 Osteoporosis 2 Lymphoma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Smoldering Multiple Myeloma 1 Paraproteinemias 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplastic Processes 1 Neoplastic Cells, Circulating 1 Neoplasms, Plasma Cell 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hyperparathyroidism, Primary 1 Hypercalcemia 1 Humoral Hypercalcemia Of Malignancy 1 Hormone Refractory Prostate Cancer 1 Hodgkin Disease 1

Interventions

Sunitinib 56 Nivolumab 37 Everolimus 29 Bevacizumab 29 pembrolizumab 24 Sorafenib 23 pazopanib 22 Axitinib 21 aldesleukin 13 Ipilimumab 13 cabozantinib 12 temsirolimus 11 Interferon alpha-2 10 Cyclophosphamide 10 Interleukin-2 9 Radiosurgery 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Immunoglobulin G 7 Erlotinib Hydrochloride 7 Disulfides 6 lenvatinib 5 fludarabine phosphate 5 avelumab 5 Radiotherapy 5 Fluorodeoxyglucose F18 5 peginterferon alfa-2b 4 atezolizumab 4 Nephrectomy 4 Interferon-alpha 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡